| Description | Esaprazole (C/63) has a dose - dependent cellular protective effect on the human gastric mucosa. |
| Synonyms | C/63 |
| molecular weight | 225.33 |
| Molecular formula | C12H23N3O |
| CAS | 64204-55-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: 70 mg/mL (310.66 mM) |
| References | 1. Ardizzone S, Sangaletti O, Ghirardosi C, Bianchi Porro G. Effect of esaprazole on gastric mucosal potential difference after oral administration of aspirin (ASA). J Int Med Res. 1986;14(6):321- 2. Dal Santo PL, Vianello F, Germana B, Dotto P, Laino G, Del Bianco T, Plebani M, Leandro G, Savarino V, Di Mario F. Esaprazole effect on acid, peptic and alkaline secretion in duodenal ulcer patients. Z Gastroenterol. 1993 Jan;31(1):11-PubMed PMID: 8447149. 3. Blandizzi C, Mengozzi G, Intorre L, Natale G, Soldani G, Del Tacca M. Inhibitory cholinergic effects of esaprazole on gastric secretion and plasma gastrin levels in the dog. Pharmacology. 1993 Apr;46(4):231-40. PubMed PMID: 8483969. 4. Blandizzi C, Natale G, De Bona M, Del Tacca M. Gastric antisecretory effects of esaprazole in rats. Digestion. 1992;51(4):226-3PubMed PMID: 1356865. |